These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20128552)

  • 41. Blepharoptosis in infantile onset Pompe disease: Histological findings and surgical outcomes.
    Chen YH; Huang PW; Liu YJ; Tsai YJ
    Mol Genet Metab Rep; 2023 Jun; 35():100969. PubMed ID: 36967722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gingival overgrowth in Pompe disease: a case report.
    de Gijt JP; van Capelle CI; Oosterhuis JW; van der Ploeg AT; van der Wal KG
    J Oral Maxillofac Surg; 2011 Aug; 69(8):2186-90. PubMed ID: 21783002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Childhood ocular myasthenia gravis.
    Kim JH; Hwang JM; Hwang YS; Kim KJ; Chae J
    Ophthalmology; 2003 Jul; 110(7):1458-62. PubMed ID: 12867410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Amblyopia of the fellow eye in assumed unilateral congenital fibrosis syndrome].
    Wolter-Roessler E; Gusek-Schneider GC
    Klin Monbl Augenheilkd; 2002 Aug; 219(8):609-11. PubMed ID: 12353179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain.
    Ebbink BJ; Poelman E; Aarsen FK; Plug I; Régal L; Muentjes C; van der Beek NAME; Lequin MH; van der Ploeg AT; van den Hout JMP
    Dev Med Child Neurol; 2018 Jun; 60(6):579-586. PubMed ID: 29573408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ophthalmologic findings in a pediatric cochlear implant population.
    Nikolaos Z; Georgios P; Angeliki C; Theodoros L; Mattheos A; Iosif V
    Eur J Ophthalmol; 2014; 24(2):254-7. PubMed ID: 23918076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycogen storage in multiple muscles of old GSD-II mice can be rapidly cleared after a single intravenous injection with a modified adenoviral vector expressing hGAA.
    Xu F; Ding E; Migone F; Serra D; Schneider A; Chen YT; Amalfitano A
    J Gene Med; 2005 Feb; 7(2):171-8. PubMed ID: 15515143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Case of Adult-onset Pompe Disease with Cerebral Stroke and Left Ventricular Hypertrophy.
    Hossain MA; Miyajima T; Akiyama K; Eto Y
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3046-3052. PubMed ID: 30093193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pompe disease: early diagnosis and early treatment make a difference.
    Chien YH; Hwu WL; Lee NC
    Pediatr Neonatol; 2013 Aug; 54(4):219-27. PubMed ID: 23632029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fractures in children with Pompe disease: a potential long-term complication.
    Case LE; Hanna R; Frush DP; Krishnamurthy V; DeArmey S; Mackey J; Boney A; Morgan C; Corzo D; Bouchard S; Weber TJ; Chen YT; Kishnani PS
    Pediatr Radiol; 2007 May; 37(5):437-45. PubMed ID: 17342521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prevalence and impact of scoliosis in Pompe disease: lessons learned from the Pompe Registry.
    Roberts M; Kishnani PS; van der Ploeg AT; Müller-Felber W; Merlini L; Prasad S; Case LE
    Mol Genet Metab; 2011 Dec; 104(4):574-82. PubMed ID: 21930409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Challenges in diagnosis and treatment of late-onset Pompe disease.
    Desnuelle C; Salviati L
    Curr Opin Neurol; 2011 Oct; 24(5):443-8. PubMed ID: 21892081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycogen Reduction in Myotubes of Late-Onset Pompe Disease Patients Using Antisense Technology.
    Goina E; Peruzzo P; Bembi B; Dardis A; Buratti E
    Mol Ther; 2017 Sep; 25(9):2117-2128. PubMed ID: 28629821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantification of muscle pathology in infantile Pompe disease.
    Schänzer A; Kaiser AK; Mühlfeld C; Kulessa M; Paulus W; von Pein H; Rohrbach M; Viergutz L; Mengel E; Marquardt T; Neubauer B; Acker T; Hahn A
    Neuromuscul Disord; 2017 Feb; 27(2):141-152. PubMed ID: 27927596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alglucosidase alfa therapy for Pompe disease in pregnancy - Case report.
    Kłos J; Kwaśniak-Butowska M; Sławek J
    J Neurol Sci; 2017 Apr; 375():167-169. PubMed ID: 28320122
    [No Abstract]   [Full Text] [Related]  

  • 56. Salmeterol enhances the cardiac response to gene therapy in Pompe disease.
    Han SO; Li S; Koeberl DD
    Mol Genet Metab; 2016 May; 118(1):35-40. PubMed ID: 27017193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Enzyme Replacement Therapy for Pompe Disease: The Long-Term Efficacy and Limitation].
    Fukuda T; Sugie H
    Brain Nerve; 2015 Sep; 67(9):1091-8. PubMed ID: 26329149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease.
    Case LE; Bjartmar C; Morgan C; Casey R; Charrow J; Clancy JP; Dasouki M; DeArmey S; Nedd K; Nevins M; Peters H; Phillips D; Spigelman Z; Tifft C; Kishnani PS
    Neuromuscul Disord; 2015 Apr; 25(4):321-32. PubMed ID: 25617983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restrictive Arteriopathy in Late-Onset Pompe Disease: Case Report and Review of the Literature.
    Malhotra K; Carrington DC; Liebeskind DS
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):e172-e175. PubMed ID: 28647415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease.
    Wang Z; Okamoto P; Keutzer J
    Mol Genet Metab; 2014 Feb; 111(2):92-100. PubMed ID: 24044919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.